Avantor

Avantor

World Rank (Jan-05-2024)
1,188
Market Cap (Jan-05-2024)
14.880 Billion USD
World Rank (Jul-30-2023)
1,247
Market Cap (Jul-30-2023)
14.366 Billion USD
World Rank (Jan-07-2022)
936
Market Cap (Jan-07-2022)
22.312 Billion USD
World Rank (Jan-01-2021)
1,100
Market Cap (Jan-01-2021)
16.280 Billion USD
Company Rank in Country in 2023
Rank in USA in July-2023 is 489
Headquarters Country
USA
Nasdaq / NYSE Code
AVTR
Market Cap (Mar-08-2026)
5.57
CEO
Michael Stubblefield
Chairman
Rajiv L Gupta
Employee Count
14,500
Employee Count as of Date
As on 2022
Headquarters City/State
Pennsylvania
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
7,512 Million USD
Annual Operating Income in USD
1,130 Million USD
Annual Net Income in USD
662 Million USD
Annual Results for Period Ending
Dec-2022 ending year
Total Assets in USD
13,464 Million USD
Total Liabilities in USD
8,608 Million USD
Total Equity in USD
4,855 Million USD
Balance Sheet for Period Ending
Dec-2022 ending year
Business Sector
Basic Materials
Chemicals
Company Website
AVANTOR
Yahoo
Yahoo @ NYSE
Company Profile

Avantor provides products and services to customers in the biopharma, healthcare, education and government, advanced technologies and applied materials industries. It offers amino acids, silicones, bio reagents, denaturants, gas, solvents, stains, dyes and minerals. The headquarters is in USA.

Facts About Company

As on Dec-2022, Avantor has 14,500 employees.

Avantor annual revenue generated for period ending Dec-2022 was 7,512 million USD.

Avantor annual net income generated for period ending Dec-2022 was 662 million USD.

Annual Results Summary

AVANTOR - Annual Results Summary - in Million USD

Year Ending:Total RevenueGross ProfitOperating IncomeNet Income
Dec-20236,9672,363857321
Dec-20227,5122,6021,130662
Dec-20217,3862,502972508
Dec-20206,3942,081707117
Dec-20196,0401,92155238
Dec-20185,8641,820414(87)
Dec-20171,247433(210)(113)
Balance Sheet Summary

AVANTOR - Balance Sheet Summary - in Million USD

Year Ending:Total AssetsTotal LiabilitiesTotal Equity
Dec-202312,9727,7205,252
Dec-202213,4648,6084,855
Dec-202113,8979,7004,197
Dec-20209,9077,2322,674
Dec-20199,7737,3112,462
Dec-20189,9129,104-3,052
Dec-201710,4479,477-2,620
Founded Year
2017
IPO Year
2019
Stock Exchange
Frankfurt
NYSE
Nasdaq Sector
Industrials
Nasdaq Industry
Biotechnology: Laboratory Analytical Instruments

Share